Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
about
Astrocytes as a source for extracellular matrix molecules and cytokinesHuman Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological DisordersDeep brain stimulation: are astrocytes a key driver behind the scene?Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammationMechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cellsAstrocytes and therapeutics for Parkinson's disease.Protection by glia-conditioned medium in a cell model of Huntington diseasePhysical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner.Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.Striatal infusion of glial conditioned medium diminishes huntingtin pathology in r6/1 mice.Gastrodin blocks neural stem cell differentiation into glial cells mediated by kainic acid.The role of the JAK-STAT pathway in neural stem cells, neural progenitor cells and reactive astrocytes after spinal cord injuryNeurological diseases as primary gliopathies: a reassessment of neurocentrism3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.Astroglia in neurological diseasesNanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.PATHOBIOLOGY OF NEURODEGENERATION: THE ROLE FOR ASTROGLIA.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Astrocytes in Alzheimer's disease.Reactive astrocytes as therapeutic targets for CNS disorders.Neuroglial roots of neurodegenerative diseases?The hallmarks of Parkinson's disease.Integrating pathways of Parkinson's disease in a molecular interaction map.Role of astrocytes in major neurological disorders: the evidence and implications.Neuroglia in ageing and disease.Astrocytes in neurodegenerative disease.Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes.Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies.NP7 protects from cell death induced by oxidative stress in neuronal and glial midbrain cultures from parkin null mice.Stratification of astrocytes in healthy and diseased brain.Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair.Immunohistochemical and morphological changes in neurons and neuroglia in the cerebral nigrostriatal structures under conditions of experimental nigral neurodegeneration.Concomitant differentiation of a population of mouse embryonic stem cells into neuron-like cells and schwann cell-like cells in a slow-flow microfluidic device.Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.The ribotoxin deoxynivalenol affects the viability and functions of glial cells.
P2860
Q21129284-A8EDCF89-5E2D-4A45-9559-1958F0E2F948Q26740032-532740AA-197E-474A-81FE-20244C6A2485Q26830147-F42DF8F6-B8F3-421E-B2D9-421927DE4C19Q28298280-DCAB3BD2-0FFE-4FE1-8FC6-DD3A091B85DDQ28392580-B4E185EB-7B63-4025-815C-C800B5DD6642Q34168266-B15FEC08-92B7-4281-99D7-F9E69A35C768Q34392509-5E77056A-E06C-4A47-A429-EB43343EA10BQ34461436-1735A43C-CD40-4CE0-B94A-96CDDE18DA25Q34660410-ADACC56A-A4DD-46BF-B9F9-231006C14DE0Q34998578-8DEF4751-1B7E-496E-BB7C-921342E01C46Q35123788-647FED64-5DC1-4DAF-8A73-AFB3765478CCQ35180002-DC6D55B8-9075-4F9D-91D3-FC453821E391Q35872654-384FEDAD-2924-4FDC-8DD8-E889C8247647Q36085198-B6C1E96B-6122-480E-B2C2-0551C9A929BDQ36819902-6BFBE7CB-5E38-4623-8452-426A69D4B0BDQ36968109-EA706648-EA4F-4768-865B-94D8E1007F18Q36998893-0E6F06B2-1A6B-4CF5-B3EA-4D9CF0FFFAA6Q37512670-59F8D67F-7976-431A-B9F3-0DD9E661A04AQ37794386-4FECC57A-2D54-4FFB-9AB2-426A91C53D1EQ37794398-7AD8537C-055F-40AF-AFF0-5A895FD14280Q37821366-3863F1DB-7F9B-489E-BF60-D3C1B7E50829Q38105645-199436FC-7055-446B-9842-83925BECBAB9Q38119873-BC5023CE-4FB9-461C-8CE6-7AAE67146424Q38174590-98CC6598-07E6-48A1-98AD-0D3ACFB06DF8Q38197951-1689BBC0-3DC0-471F-B4B4-CDD976797732Q38422519-B10905CB-B231-48AC-A30E-5F52101DDDF5Q38994712-9517B61C-9334-4AC8-913E-3FB0F751E822Q39012371-B5DA2114-193D-44EF-A3A9-51C9F7F481BEQ39139268-7C2495A3-26B4-40CA-A2E6-1CD4A29B8025Q39199926-E89C5DE7-8E75-478B-BA99-DC46F462448CQ39320908-BDCD4537-95BA-484C-A4AF-DB5D3FE9599AQ44770443-F20FCDAB-BD4B-49B0-92F7-E718D7966EE4Q45303020-C0F06DF0-9F35-4664-B3FE-32DBF2A6046BQ46197592-5A65E168-CF0C-4BE4-9721-29F4001F57E3Q46321594-5E386320-1511-4F9E-9BC6-EF1C5ABF52ABQ47194743-E19BD6D7-C9C7-4653-9F8C-805CB59F3A1BQ48313761-08FB90A8-917A-4CF4-875C-6DDC29E1449CQ48470105-0AC87C78-59B9-4B0E-A980-363C49E7C1C3Q48472483-C1075AEA-DC42-4A83-8E7C-50C559C729D4Q49059266-13EE4EBB-4A5A-42E3-9C54-FEEA3A483F2C
P2860
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@en
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@nl
type
label
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@en
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@nl
prefLabel
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@en
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@nl
P2860
P356
P1433
P1476
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
@en
P2093
Justo García de Yébenes
Maria A Mena
P2860
P304
P356
10.1177/1073858408322839
P577
2008-12-01T00:00:00Z